Yeah, i really cannot see how they would not approve ridaforolimus.whether doctors and insurance use and pay for the drug with moderate efficacy is another story.
having said that, when all this EU b.s. eer shakes out, i intend to reload a lot more in ARIA as i really believe there is no better mid development stage biotech out there right now, transforming into a viable pharma company potentially producing a billion dollar drug.
News 
Market Data 
Discover 
